Literature DB >> 8870403

Assay of neutralizing antibodies to animal rotavirus strains and human rotavirus serotype G8 by a modified method in the residents of Pune, India.

S D Kelkar1, P G Ray, S S Bedekar.   

Abstract

In the western literature, four G serotypes (G1-G4) of human rotaviruses have been found to be of a major epidemiological importance. During the analysis of rotavirus serotypes from faecal samples in Pune, over 50% of specimens could not be serotyped with the available monoclonal antibodies against G1-G4 serotypes. The results prompted to look for the prevalence of neutralizing antibodies against serotypes other than the major human serotypes (G1-G4) in adults. Neutralizing antibodies against animal rotavirus serotype, viz. G3, G6 and G10, and human rotavirus serotype G8 were determined in adult sera, by a modified technique, which is ELISA-based and mechanized. The results showed that, of the 68 sera tested at 1:100 dilution, 65 (95.58%) were reactive for G3 (SA-11), 52 (76.47%) for G6 (Bovine Lincoln), 6 (8.82%) for G10 (B223), and 40 (58.82%) for G8 (M69) serotypes. It appears that the prevalence of rotaviruses in India may be quite different from that in the developed countries.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870403

Source DB:  PubMed          Journal:  J Diarrhoeal Dis Res        ISSN: 0253-8768


  3 in total

1.  Genetic analysis of Group A rotaviruses: evidence for interspecies transmission of rotavirus genes.

Authors:  Enzo A Palombo
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

2.  Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers.

Authors:  Pratibha G Ray; Shobhana D Kelkar
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

3.  Genomic characterization of nontypeable rotaviruses and detection of a rare G8 strain in Delhi, India.

Authors:  Sumit Sharma; Vinod K Paul; Maharaj K Bhan; Pratima Ray
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.